Abstract-The pharmacological activities of five metabolites of an anti-inflammatory compound, 6-chloro-5-cyclohexylindan-1-carboxylic acid (TAI-284) were investi gated and compared with TAI-284 and phenylbutazone. The metabolite IIb (<I>ci</I>s 3'-hydroxy-cyclohexyl, &beta;-form) was almost equivalent to TAI-284 regarding anti inflammatory activity as estimated by the carrageenin edema test, and was more active than TAI-284 in the analgesic activity estimated by the phenylquinone writh ing test and determination of the ulcerogenic activity. The metabolites IIa (<I>cis</I>-4' hydroxy-cyclohexyl) and IV (<I>cis</I>-3'-hydroxy-cyclohexyl, &alpha;-form) had about half the anti-inflammatory activity and one third to one quarter the analgesic activity of TAI -284, however the degree of ulcerogenicity was considerably lower than that of TAI -284. 1 (4'-oxo-cyclohexyl) was less active, and III (<I>trans</I>-4'-hydroxy-cyclohexyl) showed the weakest activity comparable to that of phenylbutazone.
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The metabolite IIb (<I>ci</I>s 3'-hydroxy-cyclohexyl, &beta;-form) was almost equivalent to TAI-284 regarding anti inflammatory activity as estimated by the carrageenin edema test, and was more active than TAI-284 in the analgesic activity estimated by the phenylquinone writh ing test and determination of the ulcerogenic activity. The metabolites IIa (<I>cis</I>-4' hydroxy-cyclohexyl) and IV (<I>cis</I>-3'-hydroxy-cyclohexyl, &alpha;-form) had about half the anti-inflammatory activity and one third to one quarter the analgesic activity of TAI -284, however the degree of ulcerogenicity was considerably lower than that of TAI -284. 1 (4'-oxo-cyclohexyl) was less active, and III (<I>trans</I>-4'-hydroxy-cyclohexyl) showed the weakest activity comparable to that of phenylbutazone.
Antipyretic ac tivities of all five metabolites were much lower than those of TAI-284. As the phar macological activities of metabolites varied greatly according to the position of the hydroxyl group on the cyclohexane ring of TAI-284, it is feasible that the distribution pattern and affinity of the metabolites for receptors could be modified.
Anti-inflammatory drugs adminikiered at a high dosage or for a long period of time often induce gastro-intestinal disorders. TAI-284 with potent anti-inflammatory, anal gesic and antipyretic activities (1) produced at high doses penetrating ulcers in rat je junum and ileum. The toxicological properties (2) and detailed features of the ulcer de velopment following administration of the compound have been previously described (3, 4) .
It was observed that a phenobarbital pretreatment of animals reduced the toxicity of TAI-284 without altering the anti-inflammatory activity. As phenobarbital is known to be an enzyme inducer in drug metabolism (5), the metabolic mechanisms presumably play a role in the action of this drug. Recently, Aspinall reported that spironolactone pre treatment exerted no effect on the anti-inflammatory activity of indomethacin but mark edly suppressed ulcerogenic activity in adjuvant arthritis of rats (6) . He suggested that such a differential effect of spironolactone may be explained by the difference between the minimum effective doses of indomethacin exerting the two actions, the same of which is indeed worthy of consideration. The present report deals with the anti-inflammatory, analgesic, antipyretic and ulcer ogenic activities of five metabolites of TAI-284 in comparison with the parent compound and phenylbutazone, and characteristic properties of the metabolites are discussed.
Metabolites of TAI-284, shown in Table 1 Male SD-JCL rats and ICR-JCL mice were used. Test agents were suspended with 4 % gum acacia in water and administered p.o. in 1 nil per 100 g body weight to rats, and in 0.2 ml per 10 g body weight to mice. All experiments were carried out following a double-blind schedule.
1. Anti-inflammatory test The activity of metabolites of TAI-284 against carrageenin edema in rats is shown in Fig. 1 . The activity of metabolite 111) was equivalent to that of TAI-284. Metabolites 1, IIa and IV were significantly effective at 3 to 12 mg/kg, indicating the relative activities of one half to one fifth of those of TAI-284. Metabolite III displayed much less activity. as analgesic as TAI-284. Metabolites 1, Ila and IV had considerably less analgesic ac tivity than did TAI-284 but were nevertheless more active than phenylbutazone. Me tabolite 111, the least active of all, was observed to have only one twelfth the activity of TAI-284.
Antipyretic activity
In contrast to the anti-inflammatory and analgesic actions, antipyretic activities of the five metabolites were much lower than those of TAI-284 as shown in Fig. 2 . Metabo lite lib which had the strongest antipyretic activity proved to be only one third as potent as TAI-284. Metabolite I at 12.5 mg/kg, IV at 12.5 mg/kg, III at 25 mg/kg and IIa at 25 mg/kg were equivalent to TAI-284 at 0.3 mg/kg or to phenylbutazone at 25 mg/kg.
Ulcerogenicity
TAI-284 at 10 mg/kg p.o. produced quite a number of small round ulcers, mostly about 1 mm in diameter, in the jejunum and ileum, however, none were found in the stomach, duodenum and large intestine (Table 3) . Ulcers induced by metabolites I, IIa, III and IV showed a similar distribution pattern, but were significantly less in number than when TAI-284 had been administered. Metabolite lib was more potent than TAI-284 regarding the ulcerogenicity factor. 
DISCUSSION
From a stereochemical study of indomethacin by the X-ray analysis, Shen proposed the existence of a specific receptor for the anti-inflammatory action (11). Kamiya et al.
in our Chemical Research Laboratories also studied the stereochemical structure of TAI 284 using X-ray analysis (12) . As the stereochemical structures of the two compounds are quite similar, there is some possibility that TAI-284 also may have biological activities through a specific receptor (Fig. 3) .
TAI-284 was biotransformed in rats to several metabolites the chemical structures of which are quite similar, yet the therapeutic and ulcerogenic activities varied. General ly, a great difference in pharmacological activity between two stereoisomers suggests a different affinity to common receptors (13, 14) . Regarding anti-inflammatory activity, metabolite Jib was the most potent, followed by metabolites IIa, IV, I and III respective ly. Metabolite lib had greater analgesic activity than did TAI-284, but the other metabo lites Ila, 1, I V and III in the respective decreasing order were less potent than TAI-284.
Metabolites Ilb and IV are diastereoisomers the activities of which were considerably different despite a great similarity in chemical structures. The same feature was observed regarding metabolites Ila and Ill. It is postulated that the differences in activity can be attributed to the stereochernical structure which influences receptor adaptability. In contrast to anti-inflammatory and analgesic activities, all the metabolites displayed a much lower antipyretic activity than did TAI-284. This is attributed to the introduction of a hydroxy group to the cyclohexane ring of TAI-284 which would lead to reduction of lipid solubility and thus a decreased distribution to the central nervous system, as many non-steroidal anti-inflammatory agents (15, 16, 17, 18) display antipyretic action via the central nervous system.
Since so many anti-inflammatory agents also produce ulcers in the gastro-intestinal tract, a method for elimination of this side effect is the subject of intensive research. In our previous study, phentolamine, an adrenergic a-blocker, prevented ulceration induced by TAI-284 (3) without influencing the anti-inflammatory action. This differential effect of phentolamine suggests that the mechanism of ulceration is clearly distinguished from the anti-inflammatory one. In the same way metabolites Ila and IV have highly anti inflammatory properties but are less ulcerogenic.
According to Tanayama et al. (19) , the major metabolites found in rat plasma were I and 111, but metabolites Ila, llb and IV were also detectable. The pharmacological activities of TAI-284 in rats seem to be derived, at least partly, from these active metabo lites. 
